Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy is a research paper published in Journal of the American Academy of Dermatology (2023). On theSindex it has a DataRank of 0.434. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.434
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: U54-CA225088
Dermatology Foundation
Grant: R35GM142879
U.S. Department of Defense
Grant: W81XWH2110819
National Institutes of Health
Grant: K23AR077073
NHLBI NIH HHS
Grant: R01 HL174679
NCI NIH HHS
Grant: L30 CA264747
NCI NIH HHS
Grant: U54 CA225088
NIAMS NIH HHS
Grant: K23 AR080791
National Institutes of Health
Grant: 1K23AR077073-01A1
Racial Differences in Biomarkers and Therapeutic Targets for Chronic Itch
National Institutes of Health
Grant: 5R35GM142879-04
Robust, Generalizable, and Fair Machine Learning Models for Biomedicine
National Institutes of Health
Grant: 5U54CA225088-05
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
National Institute of General Medical Sciences
Dermatology Foundation
National Institute of Arthritis and Musculoskeletal and Skin Diseases
FWCI
1.96
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals